ID GCNT2_MOUSE Reviewed; 401 AA. AC P97402; Q6T5E3; DT 15-JUL-1999, integrated into UniProtKB/Swiss-Prot. DT 18-SEP-2013, sequence version 2. DT 24-JAN-2024, entry version 145. DE RecName: Full=N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase; DE Short=N-acetylglucosaminyltransferase; DE EC=2.4.1.150; DE AltName: Full=I-branching enzyme; DE AltName: Full=IGNT; DE AltName: Full=Large I antigen-forming beta-1,6-N-acetylglucosaminyltransferase; GN Name=Gcnt2; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX PubMed=9134435; DOI=10.1093/glycob/7.2.285; RA Magnet A.D., Fukuda M.; RT "Expression of the large I antigen forming beta-1,6-N- RT acetylglucosaminyltransferase in various tissues of adult mice."; RL Glycobiology 7:285-295(1997). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA]. RC STRAIN=C57BL/6J; RX PubMed=14672974; DOI=10.1101/gr.1225204; RA Zhang T., Haws P., Wu Q.; RT "Multiple variable first exons: a mechanism for cell- and tissue-specific RT gene regulation."; RL Genome Res. 14:79-89(2004). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=C57BL/6J; RX PubMed=19468303; DOI=10.1371/journal.pbio.1000112; RA Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X., RA Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y., RA Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S., RA Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R., RA Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K., RA Eichler E.E., Ponting C.P.; RT "Lineage-specific biology revealed by a finished genome assembly of the RT mouse."; RL PLoS Biol. 7:E1000112-E1000112(2009). CC -!- FUNCTION: Branching enzyme that converts linear into branched poly-N- CC acetyllactosaminoglycans. Introduces the blood group I antigen during CC embryonic development. It is closely associated with the development CC and maturation of erythroid cells. CC -!- CATALYTIC ACTIVITY: CC Reaction=a beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)- CC beta-D-GlcNAc derivative + UDP-N-acetyl-alpha-D-glucosamine = a beta- CC D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-[beta-D-GlcNAc-(1->6)]-beta-D-Gal- CC (1->4)-N-acetyl-beta-D-glucosaminyl derivative + H(+) + UDP; CC Xref=Rhea:RHEA:54820, ChEBI:CHEBI:15378, ChEBI:CHEBI:57705, CC ChEBI:CHEBI:58223, ChEBI:CHEBI:138371, ChEBI:CHEBI:138372; CC EC=2.4.1.150; CC -!- PATHWAY: Protein modification; protein glycosylation. CC -!- SUBCELLULAR LOCATION: Golgi apparatus membrane; Single-pass type II CC membrane protein. CC -!- SIMILARITY: Belongs to the glycosyltransferase 14 family. CC {ECO:0000305}. CC -!- WEB RESOURCE: Name=Functional Glycomics Gateway - GTase; Note=Gcnt2 - I CC branching beta-6-GlcNAcT2, variant 3 (IGnT); CC URL="http://www.functionalglycomics.org/glycomics/molecule/jsp/glycoEnzyme/viewGlycoEnzyme.jsp?gbpId=gt_mou_563"; CC -!- WEB RESOURCE: Name=Functional Glycomics Gateway - GTase; Note=Gcnt2 - I CC branching beta-6-GlcNAcT2, variant 1 (IGnT); CC URL="http://www.functionalglycomics.org/glycomics/molecule/jsp/glycoEnzyme/viewGlycoEnzyme.jsp?gbpId=gt_mou_587"; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; U68182; AAB39621.1; -; mRNA. DR EMBL; AY435149; AAR95650.1; -; mRNA. DR EMBL; AC133496; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AC159205; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR CCDS; CCDS26468.1; -. DR RefSeq; NP_032131.2; NM_008105.3. DR AlphaFoldDB; P97402; -. DR SMR; P97402; -. DR BioGRID; 199870; 2. DR STRING; 10090.ENSMUSP00000105820; -. DR CAZy; GT14; Glycosyltransferase Family 14. DR GlyCosmos; P97402; 4 sites, No reported glycans. DR GlyGen; P97402; 4 sites. DR iPTMnet; P97402; -. DR PaxDb; 10090-ENSMUSP00000070942; -. DR ProteomicsDB; 268858; -. DR Antibodypedia; 10005; 268 antibodies from 25 providers. DR DNASU; 14538; -. DR Ensembl; ENSMUST00000069958.15; ENSMUSP00000070942.8; ENSMUSG00000021360.17. DR GeneID; 14538; -. DR KEGG; mmu:14538; -. DR UCSC; uc007qem.2; mouse. DR AGR; MGI:1100870; -. DR CTD; 2651; -. DR MGI; MGI:1100870; Gcnt2. DR VEuPathDB; HostDB:ENSMUSG00000021360; -. DR eggNOG; KOG0799; Eukaryota. DR GeneTree; ENSGT00940000156849; -. DR InParanoid; P97402; -. DR OrthoDB; 5403607at2759; -. DR UniPathway; UPA00378; -. DR BioGRID-ORCS; 14538; 5 hits in 79 CRISPR screens. DR PRO; PR:P97402; -. DR Proteomes; UP000000589; Chromosome 13. DR RNAct; P97402; Protein. DR Bgee; ENSMUSG00000021360; Expressed in lumbar dorsal root ganglion and 219 other cell types or tissues. DR ExpressionAtlas; P97402; baseline and differential. DR GO; GO:0005794; C:Golgi apparatus; ISO:MGI. DR GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell. DR GO; GO:0008375; F:acetylglucosaminyltransferase activity; IDA:MGI. DR GO; GO:0008109; F:N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity; ISO:MGI. DR GO; GO:0036438; P:maintenance of lens transparency; ISO:MGI. DR GO; GO:0010812; P:negative regulation of cell-substrate adhesion; ISO:MGI. DR GO; GO:0030335; P:positive regulation of cell migration; ISO:MGI. DR GO; GO:0008284; P:positive regulation of cell population proliferation; IMP:UniProtKB. DR GO; GO:0010718; P:positive regulation of epithelial to mesenchymal transition; IMP:UniProtKB. DR GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IMP:UniProtKB. DR GO; GO:0034116; P:positive regulation of heterotypic cell-cell adhesion; ISO:MGI. DR GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; IMP:UniProtKB. DR GO; GO:0010608; P:post-transcriptional regulation of gene expression; IMP:UniProtKB. DR GO; GO:0006486; P:protein glycosylation; ISO:MGI. DR GO; GO:0007179; P:transforming growth factor beta receptor signaling pathway; IMP:UniProtKB. DR InterPro; IPR003406; Glyco_trans_14. DR PANTHER; PTHR19297; GLYCOSYLTRANSFERASE 14 FAMILY MEMBER; 1. DR PANTHER; PTHR19297:SF183; N-ACETYLLACTOSAMINIDE BETA-1,6-N-ACETYLGLUCOSAMINYL-TRANSFERASE; 1. DR Pfam; PF02485; Branch; 1. DR Genevisible; P97402; MM. PE 2: Evidence at transcript level; KW Glycoprotein; Glycosyltransferase; Golgi apparatus; Membrane; KW Reference proteome; Signal-anchor; Transferase; Transmembrane; KW Transmembrane helix. FT CHAIN 1..401 FT /note="N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl- FT transferase" FT /id="PRO_0000191398" FT TOPO_DOM 1..7 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 8..28 FT /note="Helical; Signal-anchor for type II membrane protein" FT /evidence="ECO:0000255" FT TOPO_DOM 29..401 FT /note="Lumenal" FT /evidence="ECO:0000255" FT CARBOHYD 37 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 255 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 315 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 389 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CONFLICT 3 FT /note="P -> L (in Ref. 1; AAB39621)" FT /evidence="ECO:0000305" FT CONFLICT 17..22 FT /note="IVFIVL -> MVCVVS (in Ref. 1; AAB39621)" FT /evidence="ECO:0000305" FT CONFLICT 43..45 FT /note="MLA -> RLS (in Ref. 1; AAB39621)" FT /evidence="ECO:0000305" FT CONFLICT 91 FT /note="V -> G (in Ref. 1; AAB39621)" FT /evidence="ECO:0000305" FT CONFLICT 148 FT /note="A -> V (in Ref. 1; AAB39621)" FT /evidence="ECO:0000305" FT CONFLICT 312 FT /note="Missing (in Ref. 1; AAB39621)" FT /evidence="ECO:0000305" FT CONFLICT 338 FT /note="H -> Q (in Ref. 1; AAB39621)" FT /evidence="ECO:0000305" FT CONFLICT 393 FT /note="I -> S (in Ref. 1; AAB39621)" FT /evidence="ECO:0000305" SQ SEQUENCE 401 AA; 45697 MW; 4DBD498E6EEEDF13 CRC64; MPPSVRYFFI VSVTTVIVFI VLYVLSFGGD QSYQKLNISD SVMLAQVCSS FIDGKSRFLW RNKLMIHEKP SCTEYVTQSH YITAPLSQEE VDFPLAYVMV IHHNFDTFAR LFRAIFMPQN IYCVHVDEKA TAEFKGAVEQ LVSCFPNAFL ASKMEPVVYG GISRLQADLN CIKDLSTSEV PWKYAINTCG QDFPLKTNKE IVQYLKGLKG KNLTPGVLPP AHAIGRTRYV HREHLSKELS YVIRTTALKP PPPHNLTIYF GSAYVALSRE FANFVLRDPR AVDLLHWSKD TFSPDEHFWV TLNRIPGVPG SMPPNASWTG NLRAVKWMDM EAKHGGCHGH YVHGICIYGN GDLQWLINSQ SLFANKFELN TYPLTVECLE LRLRERTLNQ SEIAIQPSWY F //